Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
glaxosmithkline
4
×
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
anemia
biogen
bristol-myers squibb
cancer immunotherapy
chinook therapeutics
covid-19
cystic fibrosis
duchenne muscular dystrophy
What
days
4
×
bio
roundup
biotech
summer
abbvie’s
activity
ahead
alliance
august
biofourmis
bristol
bucks
busy
buy
calls
cancer
celebrate
chance
changing
color
companies
corner
crispr
day
decisions
devices
dog
drug
drugs
fda
firm
forward
growing
hasn’t
holiday
hours
ipo
ipos
kudos
Language
unset
Current search:
glaxosmithkline
×
days
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
